{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T02:49:53Z","timestamp":1781750993379,"version":"3.54.5"},"reference-count":31,"publisher":"Norwegian Medical Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskriftet"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4045\/tidsskr.15.0684","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T04:33:29Z","timestamp":1462336409000},"page":"724-726","source":"Crossref","is-referenced-by-count":1,"title":["RhD-immunisering i\u00a0svangerskap"],"prefix":"10.4045","volume":"136","author":[{"given":"\u00c7i\u011fdem Akal\u0131n","family":"Akk\u00f6k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f8rn Moe","family":"Eggeb\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torvid","family":"Kiserud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Erik","family":"Heier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"3480430_ref_1","doi-asserted-by":"crossref","unstructured":"Bowman JM. RhD hemolytic disease of the newborn. N Engl J Med 1998; 339: 1775\u2009\u2013\u20097.","DOI":"10.1056\/NEJM199812103392410"},{"key":"3480430_ref_2","doi-asserted-by":"crossref","unstructured":"Diamond LK, Blackfan KD, Baty BJ. Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn. J Pediatr 1932; 1: 269\u2009\u2013\u2009309.","DOI":"10.1016\/S0022-3476(32)80057-0"},{"key":"3480430_ref_3","unstructured":"Hawksley JC, Lightwood R. A contribution to the study of erythroblastosis: Icterus gravis neonatorum. Q J Med 1934; 3: 155\u2009\u2013\u2009210."},{"key":"3480430_ref_4","doi-asserted-by":"crossref","unstructured":"Darrow RR. Icterus gravis (erythroblastosis) neonatorum. An examination of etiologic considerations. Arch Pathol (Chic) 1938; 25: 378\u2009\u2013\u2009417.","DOI":"10.1007\/978-94-011-6138-1_1"},{"key":"3480430_ref_5","first-page":"126\u2009\u2013\u20097","volume":"113","author":"Levine P, Stetson RE","year":"JAMA","journal-title":"5"},{"key":"3480430_ref_6","doi-asserted-by":"crossref","unstructured":"Landsteiner K, Wiener AS. An agglutinable factor in human blood recognizable by immune sera for Rhesus blood. Proc Soc Exp Biol 1940; 43: 223.","DOI":"10.3181\/00379727-43-11151"},{"key":"3480430_ref_7","doi-asserted-by":"crossref","unstructured":"Landsteiner K, Wiener AS. Studies on an agglutinogen (Rh) in human blood reacting with anti-Rhesus sera and with human isoantibodies. J Exp Med 1941; 74: 309\u2009\u2013\u200920.","DOI":"10.1084\/jem.74.4.309"},{"key":"3480430_ref_8","doi-asserted-by":"crossref","unstructured":"Klein HG, Anstee DJ. Mollison\u2019s blood transfusion in clinical medicine. 12. utg. Somerset, NJ: Wiley, 2014: 182\u2009\u2013\u20093.","DOI":"10.1002\/9781118689943"},{"key":"3480430_ref_9","first-page":"825\u2009\u2013\u20097","volume":"116","author":"Levine P, Katzin PM, Burnham L","year":"JAMA","journal-title":"9"},{"key":"3480430_ref_10","unstructured":"Levine P. The influence of the ABO system on Rh hemolytic disease. Hum Biol 1958; 30: 14\u2009\u2013\u200928."},{"key":"3480430_ref_11","first-page":"241\u2009\u2013\u20099","volume":"4","author":"Betke K, Kleihauer E","year":"Blut","journal-title":"11"},{"key":"3480430_ref_12","unstructured":"Erythroblastosis FR. Lancet 1960: 526."},{"key":"3480430_ref_13","doi-asserted-by":"crossref","unstructured":"Clarke CA. Preventing rhesus babies: the Liverpool research and follow up. Arch Dis Child 1989; 64: 1734\u2009\u2013\u200940.","DOI":"10.1136\/adc.64.12.1734"},{"key":"3480430_ref_14","unstructured":"National Institute for Health and Care Excellence (NICE). Routine antenatal anti-D prophylaxis for Rh D-negative women. http:\/\/guidance.nice.org.uk\/TA156 (9.3.2016)."},{"key":"3480430_ref_15","doi-asserted-by":"crossref","unstructured":"Tovey LA. Towards the conquest of Rh haemolytic disease: Britain's contribution and the role of serendipity. Transfus Med 1992; 2: 99\u2009\u2013\u2009109.","DOI":"10.1111\/j.1365-3148.1992.tb00142.x"},{"key":"3480430_ref_16","doi-asserted-by":"crossref","unstructured":"Koby L, Grunbaum A, Benjamin A et al. Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis? J Obstet Gynaecol Can 2012; 34: 429\u2009\u2013\u200935.","DOI":"10.1016\/S1701-2163(16)35239-2"},{"key":"3480430_ref_17","doi-asserted-by":"crossref","unstructured":"Tiblad E, Westgren M, Pasupathy D et al. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies. Acta Obstet Gynecol Scand 2013; 92: 1079\u2009\u2013\u200985.","DOI":"10.1111\/aogs.12193"},{"key":"3480430_ref_18","unstructured":"\u00c5rsberetninger 1945 og 1946. Oslo: Statens institutt for folkehelse, 1946."},{"key":"3480430_ref_19","unstructured":"Kornstad L. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969\u2009\u2013\u200983): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women. NIPH Ann 1987; 10: 3\u2009\u2013\u200910."},{"key":"3480430_ref_20","unstructured":"Flesland SJ, Sj\u00f8berg JJ. Blodtransfusjonstjenesten i\u00a0Norge. Statistikk for 2013. https:\/\/helsedirektoratet.no\/Lists\/Publikasjoner\/Attachments\/1084\/Transfusjonsstatistikk%202013.pdf (9.3.2016)."},{"key":"3480430_ref_21","doi-asserted-by":"crossref","unstructured":"Heier HE, Berge LN, Hervig T et al. Immunisering i\u00a0svangerskapet. Tidsskr Nor Legeforen 2009; 129: 2016\u2009\u2013\u20098.","DOI":"10.4045\/tidsskr.09.0186"},{"key":"3480430_ref_22","doi-asserted-by":"crossref","unstructured":"Trolle B. Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand 1989; 68: 45\u2009\u2013\u20097.","DOI":"10.3109\/00016348909087688"},{"key":"3480430_ref_23","first-page":"244\u2009\u2013\u20096","volume":"2","author":"Tovey LA, Townley A, Stevenson BJ et al","year":"Lancet","journal-title":"23"},{"key":"3480430_ref_24","doi-asserted-by":"crossref","unstructured":"MacKenzie IZ, Bowell P, Gregory H et al. Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study. Br J Obstet Gynaecol 1999; 106: 492\u2009\u2013\u20097.","DOI":"10.1111\/j.1471-0528.1999.tb08304.x"},{"key":"3480430_ref_25","doi-asserted-by":"crossref","unstructured":"Chilcott J, Lloyd Jones M, Wight J et al. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative. Health Technol Assess 2003; 7: iii-62.","DOI":"10.3310\/hta7040"},{"key":"3480430_ref_26","doi-asserted-by":"crossref","unstructured":"Daniels G, Finning K, Martin P. Noninvasive fetal blood grouping: present and future. Clin Lab Med 2010; 30: 431\u2009\u2013\u200942.","DOI":"10.1016\/j.cll.2010.02.006"},{"key":"3480430_ref_27","doi-asserted-by":"crossref","unstructured":"Wikman AT, Tiblad E, Karlsson A et al. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 2012; 120: 227\u2009\u2013\u200934.","DOI":"10.1097\/AOG.0b013e31825d33d9"},{"key":"3480430_ref_28","first-page":"752\u2009\u2013\u20098","volume":"52","author":"Clausen FB, Christiansen M, Steffensen R et al","year":"Transfusion","journal-title":"28"},{"key":"3480430_ref_29","doi-asserted-by":"crossref","unstructured":"de Haas M, van der Ploeg CPB. A nation-wide fetal RHD screening programme for targeted antenatal and postnatal anti-D. ISBT Sci Ser 2012; 7: 164\u2009\u2013\u20097.","DOI":"10.1111\/j.1751-2824.2012.01600.x"},{"key":"3480430_ref_30","unstructured":"Blaas H-G, Husebekk A, Haugen G et al. Veileder i\u00a0f\u00f8dselshjelp 2014. http:\/\/legeforeningen.no\/Fagmed\/Norsk-gynekologisk-forening\/Veiledere\/Veileder-i-fodselshjelp-2014\/ (9.3.2016)."},{"key":"3480430_ref_31","unstructured":"Evaluering av bioteknologiloven 2015. https:\/\/helsedirektoratet.no\/Lists\/Publikasjoner\/Attachments\/997\/Evaluering-av-bioteknologiloven-2015-IS-2360.pdf (9.3.2016)."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T04:21:42Z","timestamp":1567830102000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2016\/05\/kronikk\/rhd-immunisering-i-svangerskap"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"journal-issue":{"issue":"8"},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.15.0684","relation":{},"ISSN":["0029-2001"],"issn-type":[{"value":"0029-2001","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}